PAR 6.52% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Type D Response Submitted and Received by the US FDA, page-19

  1. 546 Posts.
    lightbulb Created with Sketch. 218
    LJSM, a deal has never hinged on 2x2 weekly dosing getting approved, it is something that has recently been introduced by the fanboys to try to explain why a deal has not happened.
    The management told us, they were holding off on accepting any partnership offers until after the 008 readout. Well here we are!!!!
    It is all nonsense and we are being fed nothing but B.S. from the managements mouthpieces.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.015(6.52%)
Mkt cap ! $85.7M
Open High Low Value Volume
23.0¢ 24.5¢ 23.0¢ $116.0K 491.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 33682 3
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.